Quetiapine for major depressive disorder a review of clinical effectiveness, cost-effectiveness, and guidelines
The aim of this report is to review the comparative clinical effectiveness and costeffectiveness of quetiapine versus other competing interventions such as typical antipsychotics, other atypical antipsychotics, lithium, lamotrigine, and antidepressants for the treatment of adults with MDD. This repo...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa
Canadian Agency for Drugs and Technologies in Health
2020, January 30, 2020
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The aim of this report is to review the comparative clinical effectiveness and costeffectiveness of quetiapine versus other competing interventions such as typical antipsychotics, other atypical antipsychotics, lithium, lamotrigine, and antidepressants for the treatment of adults with MDD. This report also aims to identify evidence-based guidelines regarding the use of quetiapine for MDD. |
|---|---|
| Physical Description: | 1 PDF file (43 pages) illustrations |